The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma
Open Access
- 13 June 2012
- journal article
- Published by Springer Nature in Molecular Cancer
- Vol. 11 (1) , 40
Abstract
Hypermethylation of promotor CpG islands is a common mechanism that inactivates tumor suppressor genes in cancer. Genes belonging to the RASSF gene family have frequently been reported as epigenetically silenced by promotor methylation in human cancers. Two members of this gene family, RASSF1A and RASSF5A have been reported as methylated in neuroblastoma. Data from our previously performed genome-wide DNA methylation array analysis indicated that other members of the RASSF gene family are targeted by DNA methylation in neuroblastoma.Keywords
This publication has 47 references indexed in Scilit:
- Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumorsBMC Genomics, 2011
- Identification of epigenetically regulated genes that predict patient outcome in neuroblastomaBMC Cancer, 2011
- MicroRNA Mediates DNA Demethylation Events Triggered by Retinoic Acid during Neuroblastoma Cell DifferentiationCancer Research, 2010
- Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequencesMolecular Cancer, 2010
- Human RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora B activation and chromosomal congression during mitosisBiochemical Journal, 2010
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onsetProceedings of the National Academy of Sciences, 2010
- RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic markerBritish Journal of Cancer, 2009
- RASSF7 Is a Member of a New Family of RAS Association Domain–containing Proteins and Is Required for Completing MitosisMolecular Biology of the Cell, 2008
- Genetic and epigenetic changes in the common 1p36 deletion in neuroblastoma tumoursBritish Journal of Cancer, 2007
- Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancerOncogene, 2007